Ibrahim Janahi
Acting Chief Medical Officer at Sidra Medicine
Prof. Janahi’s clinical expertise includes interventional pulmonology, chronic lung diseases with genetic basis, and rare lung diseases in children. His research includes primary ciliary dyskinesia, pulmonary hypertension in children, the genetic basis of lung diseases, and non-invasive monitoring of airway inflammation.
In addition to this role as the Acting CMO, Prof. Janahi is also the Chair of Medical Education, Designated Institutional Officer and the Division Chief of Pulmonology at Sidra Medicine.
In his capacity as the Chair of Medical Education, Professor Janahi is responsible for coordinating undergraduate and graduate medical training, monitoring the Continuous Medical Education (CME), and Continuing Professional Development (CPD) of senior medical staff. He also oversees the fellowship programs and accredited residency programs from the Accreditation Council for Graduate Medical Education – International (ACGMEI).
Prof. Janahi is also a Professor of Clinical Pediatrics Weill Cornell Medicine-Qatar, Executive Director of Medical Research at HMC and Chairman of Qatar's National Permanent Licensing Committee. He is the founder-president of the Gulf Society for Pediatric Respirology and a founding member of the Arab Pediatric Pulmonology Association (APPA). He is a member of the exam committee of the Arab Board and an examiner for certifying boards and qualifying examinations, including the Royal College of Pediatrics and Child Health, UK.